Bruker's Q4 Revenues Drop 9 Percent; Shares Rise as It Beats Estimates

Though the firm's revenues were down year over year for the quarter, its full-year 2008 revenues increased 7 percent. Investors also sent Bruker's shares up in early trade, as the firm handily beat analysts' consensus estimate for EPS.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.